Immunocompromised patients with bladder cancer who undergo TURBT followed by BCG immunotherapy have worse survival outcomes compared to non-immunocompromised patients, a study suggests.

RPM improves postoperative functional recovery and symptoms among patients undergoing surgery for cancer, according to a study.

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Millions who buy their health insurance on Affordable Care Act marketplaces will pay higher premiums next year.